MEDICAL

RITUXIMAB IS A MONOCLONAL ANTIBODY USED IN THE TREATMENT OF CERTAIN TYPES OF HAEMATOLOGICAL MALIGNANCIES. WHICH ANTIGEN DOES IT TARGET

  • A. CD56
  • B. CD20 ✓
  • C. CD4
  • D. CD8

 

Rituximab targets CD20, which is a specific B-cell surface antigen. In other words, Rituximab targets the CD20 antigen. CD20 is a cell surface protein that is primarily expressed on B cells, making it an ideal target for rituximab in the treatment of B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advantages of local domestic helper.
Blogarama - Blog Directory